Why the study?
Multiple scores have been proposed to guide post-PCI risk stratification, but their comparative performance to predict post-discharge ischaemic or bleeding events required assessment.
Do PRECISE-DAPT, PARIS, and CREDO-Kyoto risk scores accurately predict post-discharge ischaemic or bleeding events in patients treated with latest-generation drug-eluting stents?
Do PRECISE-DAPT, PARIS, and CREDO-Kyoto risk scores accurately predict post-discharge ischaemic or bleeding events in patients treated with latest-generation drug-eluting stents?
In a contemporary all-comer population, the CREDO-Kyoto risk score showed moderate predictive capability for post-discharge ischaemic and bleeding events, outperforming PARIS and PRECISE-DAPT.
Answers are grounded in this paper and cite their sources.
Existing scores show marginal-moderate external performance; leaves open need for robust, validated tools before clinical adoption.
BACKGROUND: Multiple scores have been proposed to guide risk stratification after percutaneous coronary intervention. This study assessed the performance of the PRECISE-DAPT, PARIS and CREDO-Kyoto risk scores to predict post-discharge ischaemic or bleeding events. METHODS: A total of 1491 patients treated with latest-generation drug-eluting stent implantation were evaluated. Risk scores for post-discharge ischaemic or bleeding events were calculated and directly compared. Prognostic performance of both risk scores was assessed with calibration, Harrell's c‑statistics net reclassification index and decision curve analyses. RESULTS: Post-discharge ischaemic events occurred in 56 patients (3.8%) and post-discharge bleeding events in 34 patients (2.3%) within the first year after the invasive procedure. C‑statistics for the PARIS ischaemic risk score was marginal (0.59, 95% confidence interval (CI) 0.51-0.68), whereas the CREDO-Kyoto ischaemic risk score was moderate (0.68, 95% CI 0.60-0.75). With regard to post-discharge bleeding events, CREDO-Kyoto displayed moderate discrimination (c-statistic 0.67, 95% CI 0.56-0.77), whereas PRECISE-DAPT (0.59, 95% CI 0.48-0.69) and PARIS (0.55, 95% CI 0.44-0.65) had a marginal discriminative capacity. Net reclassification index and decision curve analysis favoured CREDO-Kyoto-derived bleeding risk assessment. CONCLUSION: In this contemporary all-comer population, PARIS and PRECISE-DAPT risk scores were not resilient to independent testing for post-discharge bleeding events. CREDO-Kyoto-derived risk stratification was associated with a moderate predictive capability for post-discharge ischaemic or bleeding events. Future studies are warranted to improve risk stratification with more focus on robustness and rigorous testing.
No takes yet. Share an insight, caveat, or question.
Rozemeijer et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: